Silver Book Fact

Based on rates of admission in 1998, delaying admission of Alzheimer’s patients to nursing homes by 1 month could save as much as $1.12 billion a year.

Leon, Joel, Chang-Kuo Cheng, and Peter J. Neumann. Alzheimer s Disease Care: Costs and potential savings. Health Affairs. 1998; 17(6): 206-16. http://content.healthaffairs.org/cgi/content/abstract/17/6/206?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=leon&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

Reference

Title
Alzheimer s Disease Care: Costs and potential savings
Publication
Health Affairs
Publication Date
1998
Authors
Leon, Joel, Chang-Kuo Cheng, and Peter J. Neumann
Volume & Issue
Volume 17, Issue 6
Pages
206-16
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, 21 new medicines are currently in development for the treatment of Parkinson’s disease.  
  • Donepezil, a new Alzheimer’s medication, increased prescription costs to $1,000 per patient, however the overall health care costs decreased from $11,947 to $8,056.  
  • A recent study showed that memantine, a medicine approved to treat moderate-to-severe Alzheimer’s, significantly slows cognitive decline and reduces the need for caregiving by 45.8 hours per month.  
  • Studies have shown that active medical management of Alzheimer’s disease can significantly improve quality-of-life for the individual through all stages of the disease.  
  • Use of existing or new drugs/compounds for Alzheimer’s prevention could result in a delay of onset of between 2 and 5 years.